Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral acetazolamide for edema in acute decompensated heart failure
IRCT20250919067292N1Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Acetazolamide with Placebo (2 arms). Primary endpoint: Decongestion and edema resolution. Started Dec 2025; status: recruiting.
02
Drugs
acetazolamide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT20250919067292N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250919067292N1.